Moreover, the utilization of prolactin (PRL) hormone, a key component in mammary differentiation pathways, has been shown to suppress this oncogenic pathway, shedding light on the significant role of differentiation pathways in tumor suppression [32]. This evidence concerns the gene PRL and neoplasm.